PP
EDIT icon

PDT Partners’s Editas Medicine EDIT Stock Holding History

PDT Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-39,546
Closed -$135K – 746
2024
Q3 		$135K Sell
39,546
-206,991
-84% -$901K 0.01% 680
2024
Q2 		$1.15M Buy
246,537
+196,041
+388% +$1.11M 0.11% 307
2024
Q1 		$375K Buy
+50,496
New +$420K 0.04% 500
2023
Q4 		– Sell
-156,515
Closed -$1.22M – 571
2023
Q3 		$1.22M Buy
156,515
+74,374
+91% +$638K 0.15% 230
2023
Q2 		$676K Buy
82,141
+50,743
+162% +$442K 0.09% 331
2023
Q1 		$228K Sell
31,398
-78,202
-71% -$695K 0.03% 493
2022
Q4 		$972K Sell
109,600
-15,158
-12% -$166K 0.16% 231
2022
Q3 		$1.53M Buy
124,758
+37,793
+43% +$589K 0.23% 111
2022
Q2 		$1.03M Buy
86,965
+28,764
+49% +$385K 0.09% 387
2022
Q1 		$1.11M Sell
58,201
-48,136
-45% -$895K 0.1% 336
2021
Q4 		$2.82M Buy
106,337
+39,137
+58% +$1.35M 0.22% 167
2021
Q3 		$2.76M Sell
67,200
-61,700
-48% -$3.38M 0.2% 210
2021
Q2 		$7.3M Buy
128,900
+61,111
+90% +$2.26M 0.48% 9
2021
Q1 		$2.85M Buy
+67,789
New +$3.86M 0.2% 208
2020
Q4 		– Sell
-19,279
Closed -$541K – 729
2020
Q3 		$541K Buy
+19,279
New +$628K 0.04% 431
2020
Q2 		– Sell
-14,511
Closed -$288K – 702
2020
Q1 		$288K Sell
14,511
-94,537
-87% -$2.38M 0.02% 484
2019
Q4 		$3.23M Buy
109,048
+17,648
+19% +$441K 0.2% 146
2019
Q3 		$2.08M Sell
91,400
-48
-0.1% -$1.19K 0.12% 201
2019
Q2 		$2.26M Buy
91,448
+80,917
+768% +$1.93M 0.13% 172
2019
Q1 		$257K Sell
10,531
-87,943
-89% -$1.99M 0.01% 369
2018
Q4 		$2.24M Sell
98,474
-51
-0.1% -$1.39K 0.13% 183
2018
Q3 		$3.13M Sell
98,525
-52,638
-35% -$1.7M 0.13% 189
2018
Q2 		$5.42M Buy
151,163
+238
+0.2% +$8.43K 0.21% 155
2018
Q1 		$5M Buy
+150,925
New +$5.38M 0.17% 165

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's EDIT Position: Q4 2024 in Review

PDT Partners sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 39,546 shares — an estimated $135K sold.

PDT Partners first reported a position in EDIT in Q1 2018 and held it in 24 quarters. The position peaked at $7.3M in Q2 2021. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • PDT Partners reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • PDT Partners sold 39,546 Editas Medicine shares in Q4 2024, an estimated $135K.
  • PDT Partners first reported a position in Editas Medicine in Q1 2018 and held it in 24 quarters.
  • PDT Partners's Editas Medicine position peaked at $7.3M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.